(Q84592604)
English
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM
scientific article published on 28 September 2009
Statements
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study (English)
Bella Kaufman
Michael R Clemens
Poonamalle P Bapsy
Ashok Vaid
Sergei Tjulandin
Michaela Jahn
Michaela Lehle
Andrea Feyereislova
Cédric Révil
28 September 2009